Description
UL is organizing a mega pharma event in association with Indian Drug Manufacturers Association [IDMA] called 'Indian Pharma Regulatory & Compliance Summit 2014' (IPRCS) at the JW Marriott Hotel, Mumbai, India on 20th February 2014. The key features of the IPRCS summit includes a major panel discussion on the ever-changing Indian pharma industry, the regulations, quality and compliances for EU and FDA inspection and the perspectives of the leaders of the industry on how India can upgrade its GMP and cGMP practices. The attendees of this summit will get a rare opportunity to learn and network with the industrial geeks, CxO, R&D heads and global policy makers. Industrial honchos who will provide valuable perspectives in the panel discussion includes S.V. Veerramani, CMD of Fourrts (India) Laboratories Pvt Ltd, S.M. Mudda, executive director of Micro Labs Ltd, Dr Rajiv Modi, M.D. Of Cadila Pharma, Dr Ranjana Pathak, VP of Cipla Ltd. Apart from this, Ellen Leinfuss, SVP, UL EduNeering, Scott Barnard, VP Advisory Services, UL EduNeering, Dr Kavita Mehrotra, Global Strategic Head, UL EduNeering will provide insights on other key issues that influence the industry. Keynote Address by: Dr V.G. Somani (Joint Drug controllers, India) About UL UL is an eminent global science organization with 11,000 global employees working for it. The company's partner, EduNeering group has emerged as a leader in technology based regulatory compliance training and education. The company works with more than 400 life science companies, offering its award-winning ComplianceWire technology. Recently UL has been granted a further extension of CRADA (Corporate Research and Development Agreement) thereby enhancing mutual opportunities to continue the commitment towards GMP, cGMP and US FDA inspector training utilizing the best in class technical expertise.
